AML and chronic myelogenous leukemia (CML) cells in the acute phase also showed increased expression levels for DNMT1, DNMT3A and DNMT3B when compared to normal bone marrow cells. Here, DNMT1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.